SpineX

Los Angeles, United States Founded: 2018 • Age: 8 yrs
Neuromodulation devices for neurological disorders are developed and offered.
Annual revenue - Latest available
Total funding - 4 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products 2 Services tracked
Competitors 9 Brand Intelligence

About SpineX

SpineX is a company based in Los Angeles (United States) founded in 2018. SpineX offers products and services including SCiP™ and SCONE™. SpineX operates in a competitive market with competitors including ONWARD, Nalu Medical, Atlantic Therapeutics, Synchron and MyndTec, among others.

  • Headquarter Los Angeles, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    NIH

    & 1 more

  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of SpineX

SpineX offers a comprehensive portfolio of products and services, including SCiP™ and SCONE™.

Product name locked
Category locked
Primary

Treats cerebral palsy through non-invasive spinal cord stimulation.

Product name locked
Category locked
Locked

Addresses urinary incontinence via electrical stimulation for neurogenic bladder.

People of SpineX

Headcount 10-50
Employee Profiles 2
Employee Profiles
People
Parag Gad
Co-Founder & CEO

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of SpineX

Investors in SpineX

SpineX has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NIH and HHS.

All
Institutional
Investor Description Founded Year Domain Location
Drug discovery services are provided to the biopharma sector.
Locked Locked Locked
Public health and human services are overseen by HHS.
Locked Locked Locked
Premium access

Investor details for SpineX

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by SpineX

Investments
Premium access

Investment portfolio details for SpineX

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - SpineX

Premium access

Detailed financials for SpineX

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Spinex Comparisons

SpineX Primary company
Description
Neuromodulation devices for neurological disorders are devel...
Location
Los Angeles, United States
Founded Year
2018
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for SpineX

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of SpineX

SpineX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ONWARD, Nalu Medical, Atlantic Therapeutics, Synchron and MyndTec, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Therapeutic devices for spinal cord injuries are developed and delivered.
Locked Locked Locked
Developer of a neurostimulation system for managing intractable chronic pain
Locked Locked Locked
Non-invasive wearable devices for pelvic floor strengthening are developed.
Locked Locked Locked
Implantable bioelectronics are developed for neurological condition treatments.
Locked Locked Locked
Functional electrical stimulation therapy is developed for upper limb paralysis.
Premium access

Detailed competitors of SpineX

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Spinex

Premium access

Complete news archive for SpineX

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about SpineX

SpineX was founded in 2018 and raised its 1st funding round 3 years after it was founded.

SpineX is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.

SpineX was founded in 2018 in Los Angeles, United States, within the medical device sector focused on neuromodulation. Noninvasive devices such as Scone are provided to address urinary incontinence associated with neurogenic bladder from spinal cord injuries, multiple sclerosis, or stroke. Additionally, the Spinal Cord Innovation in Pediatrics (SCiP) device is utilized to target cerebral palsy via spinal cord neuromodulation, supporting treatment for affected individuals.

SpineX's top competitors include ONWARD, Synchron and Nalu Medical.

SpineX offers SCiP™ and SCONE™.

SpineX has 2 investors. Key investors include NIH, and HHS.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available